Invasive carcinoma of breast | Breast Carcinoma In situ
Item
participants must have histologically or cytologically confirmed invasive or in-situ carcinoma of the breast
boolean
C0853879 (UMLS CUI [1])
C0678222 (UMLS CUI [2,1])
C0444498 (UMLS CUI [2,2])
Sentinel lymph node mapping | Excision of axillary lymph nodes
Item
participants must have undergone sentinel lymph node mapping or axillary dissection
boolean
C1519247 (UMLS CUI [1])
C0193867 (UMLS CUI [2])
Other Coding Measurement Preoperative | Status pre- Edema Volume low
Item
participants must have had a pre-operative perometer measurement, and consecutive measurement at 4-6 month intervals prior to the onset of low volume edema (>5% from baseline)
boolean
C3846158 (UMLS CUI [1,1])
C0242485 (UMLS CUI [1,2])
C0445204 (UMLS CUI [1,3])
C0332152 (UMLS CUI [2,1])
C0013604 (UMLS CUI [2,2])
C0449468 (UMLS CUI [2,3])
C0205251 (UMLS CUI [2,4])
Age
Item
age > 18 years
boolean
C0001779 (UMLS CUI [1])
Life Expectancy
Item
life expectancy of greater than 1 year
boolean
C0023671 (UMLS CUI [1])
Other Coding Measurement | Relative Volume Change Percentage
Item
participants must have a perometer measurement of 5% or greater volume difference (rvc) to qualify for randomization
boolean
C3846158 (UMLS CUI [1,1])
C0242485 (UMLS CUI [1,2])
C1442097 (UMLS CUI [2,1])
C0392747 (UMLS CUI [2,2])
C0439165 (UMLS CUI [2,3])
Informed Consent
Item
ability to understand and willingness to sign a written informed consent document
boolean
C0021430 (UMLS CUI [1])
Protocol Compliance
Item
willingness to comply with required follow up perometer measurements and clinical visits
boolean
C0525058 (UMLS CUI [1])
Neoplasm Metastasis Thoracic region | Neoplasm Metastasis Cervical region | Advanced disease Locally Thoracic region | Advanced disease Locally Cervical region
Item
known metastatic disease or other locally advanced disease in the thoracic or cervical regions
boolean
C0027627 (UMLS CUI [1,1])
C0817096 (UMLS CUI [1,2])
C0027627 (UMLS CUI [2,1])
C0556956 (UMLS CUI [2,2])
C0679246 (UMLS CUI [3,1])
C1517927 (UMLS CUI [3,2])
C0817096 (UMLS CUI [3,3])
C0679246 (UMLS CUI [4,1])
C1517927 (UMLS CUI [4,2])
C0556956 (UMLS CUI [4,3])
Patient Unavailable Follow-up
Item
any patient who will not be returning routinely for follow-up
boolean
C0030705 (UMLS CUI [1,1])
C0686905 (UMLS CUI [1,2])
C3274571 (UMLS CUI [1,3])
Metastatic malignant neoplasm to brain | Prognosis bad | Progressive neurologic dysfunction Interferes with Evaluation Neurological event | Progressive neurologic dysfunction Interferes with Evaluation Adverse event
Item
known brain metastases will be excluded from this clinical trial because of their poor prognosis and because they often develop progressive neurologic dysfunction that would confound the evaluation of neurologic and other adverse events
boolean
C0220650 (UMLS CUI [1])
C0278252 (UMLS CUI [2])
C4013375 (UMLS CUI [3,1])
C0521102 (UMLS CUI [3,2])
C1261322 (UMLS CUI [3,3])
C1320718 (UMLS CUI [3,4])
C4013375 (UMLS CUI [4,1])
C0521102 (UMLS CUI [4,2])
C1261322 (UMLS CUI [4,3])
C0877248 (UMLS CUI [4,4])
Lymphedema praecox
Item
history of primary lymphedema
boolean
C0238261 (UMLS CUI [1])
Operative procedure on head | Radiotherapy to head | Operation on neck | Radiotherapy to neck | Operative procedure on upper extremity | UPPER EXTREMITY RADIATION | Operation on trunk | Therapeutic radiology procedure Trunk
Item
history of prior surgery or radiation to the head, neck, upper limb, or trunk
boolean
C0195772 (UMLS CUI [1])
C1997353 (UMLS CUI [2])
C0185773 (UMLS CUI [3])
C1997944 (UMLS CUI [4])
C0186318 (UMLS CUI [5])
C0749835 (UMLS CUI [6])
C0185774 (UMLS CUI [7])
C1522449 (UMLS CUI [8,1])
C0460005 (UMLS CUI [8,2])
Axillary lymph node Malignant Neoplasm Causing Lymphedema | Etiology Recurrent disease
Item
evidence that axillary lymph node malignancy is causing lymphedema due to recurrence as per physician discretion
boolean
C0729594 (UMLS CUI [1,1])
C0006826 (UMLS CUI [1,2])
C0678227 (UMLS CUI [1,3])
C0024236 (UMLS CUI [1,4])
C0015127 (UMLS CUI [2,1])
C0277556 (UMLS CUI [2,2])
Lymphatic mapping Bilateral | Lymph node excision Bilateral
Item
any patient who has bilateral lymph node mapping or dissection
boolean
C1518048 (UMLS CUI [1,1])
C0238767 (UMLS CUI [1,2])
C0024203 (UMLS CUI [2,1])
C0238767 (UMLS CUI [2,2])
Cellulitis
Item
any patient with a current case of cellulitis
boolean
C0007642 (UMLS CUI [1])
Cancer Other | Exception Disease Free of | Exception Low Risk Recurrent Malignant Neoplasm | Exception Carcinoma in situ of uterine cervix Treated | Exception Basal cell carcinoma Treated | Exception Squamous cell carcinoma of skin Treated
Item
patients with a history of a different malignancy are ineligible except for the following circumstances. individuals with a history of other malignancies are eligible if they have been disease-free for at least 5 years and are deemed by the investigator to be at low risk for recurrence of that malignancy. individuals with the following cancer are eligible if diagnosed and treated within the past 5 years: cervical cancer in situ, and basal cell or squamous cell carcinoma of the skin
boolean
C1707251 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0012634 (UMLS CUI [2,2])
C0332296 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C3538919 (UMLS CUI [3,2])
C1458156 (UMLS CUI [3,3])
C1705847 (UMLS CUI [4,1])
C0851140 (UMLS CUI [4,2])
C1522326 (UMLS CUI [4,3])
C1705847 (UMLS CUI [5,1])
C0007117 (UMLS CUI [5,2])
C1522326 (UMLS CUI [5,3])
C1705847 (UMLS CUI [6,1])
C0553723 (UMLS CUI [6,2])
C1522326 (UMLS CUI [6,3])